Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Halcinonide
Drug ID BADD_D01050
Description Halcinonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and is distributed as a cream and ointment. Halcinonide is marketed under the brand name Halog® by Ranbaxy Laboratories Inc. Research suggests that clobetasol propionate demonstrates superior pharmacologic efficacy in the treatment of psoriasis when compared to halcinonide.
Indications and Usage Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Marketing Status Prescription; Discontinued
ATC Code D07AD02
DrugBank ID DB06786
KEGG ID D01308
MeSH ID D006206
PubChem ID 443943
TTD Drug ID D06IIB
NDC Product Code 0378-8056; 10631-096; 71428-011; 57664-698; 46439-8717; 0003-0249
Synonyms Halcinonide | Alcinonide | Halciderm | Halcimat | Halog | Dermalog | SQ-18,566 | SQ 18,566 | SQ18,566
Chemical Information
Molecular Formula C24H32ClFO5
CAS Registry Number 3093-35-4
SMILES CC1(OC2CC3C4CCC5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CCl)C)O)F)C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrophy08.03.04.001--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cataract subcapsular06.06.01.002--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact10.01.01.003; 23.03.04.004; 12.03.01.040--Not Available
Dermatitis infected23.03.04.024; 11.01.12.011--Not Available
Dry skin23.03.03.001--
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
Erythema23.03.06.001--Not Available
Folliculitis23.09.04.007; 11.01.12.018--
Hirsutism23.02.04.001; 05.05.01.005--
Hypertension24.08.02.001--
Hypertrichosis23.02.04.002--
Infection11.01.08.002--Not Available
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Muscular weakness17.05.03.005; 15.05.06.001--
Oedema14.05.06.010; 08.01.07.006--Not Available
Peptic ulcer07.04.07.001--Not Available
Pruritus23.03.12.001--
Pyoderma23.09.01.007; 11.01.12.009--Not Available
Secondary adrenocortical insufficiency14.11.01.014; 05.01.02.003--Not Available
Skin atrophy23.01.05.001--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
Swelling08.01.03.015--Not Available
Skin maceration23.03.03.016--Not Available
Pigmentation disorder23.05.03.001--Not Available
The 1th Page    1    Total 1 Pages